Table of Contents
Journal of Allergy
Volume 2012, Article ID 182090, 9 pages
http://dx.doi.org/10.1155/2012/182090
Review Article

Interleukin-4 in the Generation of the AERD Phenotype: Implications for Molecular Mechanisms Driving Therapeutic Benefit of Aspirin Desensitization

1Asthma and Allergic Disease Center, Beirne Carter B. Center for Immunology Research, University of Virginia Health System, Charlottesville, VA 22908, USA
2Department of Medicine, University of Virginia Health System, Charlottesville, VA 22908, USA
3Department of Otolaryngology—Head and Neck Surgery, University of Virginia Health System, Charlottesville, VA 22908, USA

Received 1 July 2011; Accepted 4 October 2011

Academic Editor: Hae-Sim Park

Copyright © 2012 John W. Steinke et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

John W. Steinke, Spencer C. Payne, and Larry Borish, “Interleukin-4 in the Generation of the AERD Phenotype: Implications for Molecular Mechanisms Driving Therapeutic Benefit of Aspirin Desensitization,” Journal of Allergy, vol. 2012, Article ID 182090, 9 pages, 2012. https://doi.org/10.1155/2012/182090.